Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 13357
TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783497(Single Diastereomer 2 of Trans-2-((4-(5-((((R)-1-(...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783496((1S,2S)-2-((6-(5-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783492((1S,2S)-2-((6-(4-((((R)-1-(2-chlorophenyl)ethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783506(Single Diastereomer 2 of Cis-2-((6-(4-((((R)-1-(2-...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783505((1R,2R)-2-((6-(4-((((R)-1-(2-chlorophenyl)ethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783503(Single Diastereomer 1 of Trans-2-((4-(3-((((R)-1-(...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783502(Trans-2-((4-(3-((((R)-1-(2-chlorophenyl)ethoxy)car...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783500(Single Diastereomer 1 of Cis-2-((4-(3-((((R)-1-(2-...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783499(Cis-2-((4-(3-((((R)-1-(2-chlorophenyl)ethoxy)carbo...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783546((1S,2S)-2-((6-(5-((((R)-1-(2-chlorophenyl)ethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783542((1S,2S)-2-((2-methyl-6-(3-methyl- 4-(((((R)-pentan...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783541((1S,2S)-2-((6-(5-(((R)-1-(2- chlorophenyl)ethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783540((1S,2S)-2-((6-(5-((((R)-1-(2- fluorophenyl)ethoxy)...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783527((1S,2S)-2-((6-(4-((((R)-1-(2- fluorophenyl)ethoxy)...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783525((1S,2S)-2-((2-methyl-6-(3-methyl- 4-((((R)-1-(o- t...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783524((1S,2S)-2-((6-(4-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783537((1S,2S)-2-((2-methyl-6-(1-methyl- 5-((((R)-1- phen...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783534((1S,2S)-2-((6-(3-methyl-4-((((R)-1- phenylethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783532(Cis-2-((2-methyl-6-(3-methyl-4- ((((R)-1- phenylet...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783509((1S,2S)-2-((6-(4-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783507(Single Diastereomer 1 of Cis-2-((6-(4-((((R)-1-(2-...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783521((1S,2S)-2-((6-(4-((((R)-1-(2- bromophenyl)ethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783520((1S,2S)-2-((2-methyl-6-(3-methyl- 4-((((R)-1- phen...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783519((1S,2S)-2-((6-(4-((((R)-1- cyclopentylethoxy)carbo...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783517((1S,2S)-2-((6-(4-((((R)-1-(2-fluorophenyl)ethoxy)c...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783516((1S,2S)-2-((4-(5-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783530((1S,2S)-2-((6-(4-((((R)-1-(2- methoxyphenyl)ethoxy...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783529((1S,2S)-2-((6-(3-methyl-4-((((R)-1- (2- (trifluoro...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783528((1S,2S)-2-((6-(4-((((2- chlorobenzyl)oxy)carbonyl)...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783495((1S,2S)-2-((6-(5-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783538((1S,2S)-2-((2-methyl-6-(1-methyl- 5-((((R)-1-(2- (...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783504((1S,2S)-2-((6-(4-((((R)-1-(2- chloropyridin-3- yl)...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783536((1S,2S)-2-((2-methyl-6-(1-methyl- 5-((((R)-1- phen...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783535((1S,2S)-2-((6-(4-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783533(Cis-2-((6-(3-methyl-4-((((R)-1- phenylethoxy)carbo...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783531((1S,2S)-2-((6-(4-((((R)-1-(2- methoxyphenyl)ethoxy...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783545((1S,2S)-2-((2-methyl-6-(1-methyl- 5-(((((R)-pentan...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783513(Single Diastereomer 2 of (1S,2S)-2-((6-(4-(((−1-(2...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783512((1S,2S)-2-((6-(4-(((1-(2- fluoropyridin-3- yl)etho...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783543((1S,2S)-2-((6-(5-((((R)-1-(2- fluorophenyl)ethoxy)...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783511(Single Diastereomer 1 of (1S,2S)-2-((6-(4-(((1-(2-...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783510((1S,2S)-2-((6-(4-(((1-(2- fluoropyridin-3- yl)etho...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783508((1S,2S)-2-((2-methyl-6-(3-methyl- 4-((((R)-1-(pyri...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783539((1S,2S)-2-((6-(5-((((R)-1- cyclopentylethoxy)carbo...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783522((1S,2S)-2-((6-(4-((((R)-1-(2- chloropyridin-3- yl)...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783518((1S,2S)-2-((2-methyl-6-(3-methyl- 4-((((R)-1-(2- (...)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783498(Single Diastereomer 1 of Trans-2-((4-(5-((((R)-1-(...)
Affinity DataIC50: 425nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783514((1S,2S)-2-((6-(3-((((R)-1-(2- chlorophenyl)ethoxy)...)
Affinity DataIC50: 425nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783544((1S,2S)-2-((6-(5-((((R)-1- cyclopentylethoxy)carbo...)
Affinity DataIC50: 425nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetLysophosphatidic acid receptor 1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM783526(Cis-2-((2-methyl-6-(3-methyl-4-((((R)-1-(pyridin-3...)
Affinity DataIC50: 425nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: